Istanbul Medikal

Human health comes first

Istanbul Medical and Health Products Co. was established in 2002. The company has 17 years experience of developing wound care products. Istanbul Medical aims to provide quality health services with the basic principle of ‘Human health comes first’. The company offers quality products at competitive prices and draws on the invaluable experience of healthcare professionals. Our area of interest is in wound care products and in recent years we have focused our efforts on patients with Epidermolysis Bullosa.

Our company specialises in providing solutions for wound care and we have continually developed our products over the years. We are proud that we are known not only domestically, but are gaining an international reputation in wound care symposia and congresses.

Epidermolysis Bullosa, sometimes known as Butterfly Disease, is a group of genetic skin conditions that cause the skin to blister and tear at the slightest touch. With more than 30 variants known, the disease manifests as different severities dependent on the type. The mainstay of treatment is wound care which involves keeping fragile skin protected from potential irritants. In our research and development studies, we are improving product design and functionality in order to better meet the needs of EB patients.

Our brand is growing and our company is achieving sustainable growth despite a fiercely competitive environment and international and domestic economic instability. In the last year, we have surpassed each of our performance goals and remain on track to achieve even higher in the coming year.

We are in the process of developing a hugely exciting project which involves bringing EB patients and their families to a design room in our factory in order to involve them at every stage of the production process. Our goal is to better understand the individual needs of each patient and use this information to develop a wider range of products. We understand that every patient is different and we consider patient feedback to be at the core of our development process. We have influenced people’s lives positively in the last 17 years and it is important that we continue to do this in the coming years by involving patients and their families as much as possible.

We are proud of our achievements within our domestic market in Turkey and we look forward to translating those achievement into international platforms too.
 
X
//]]>